Results for the year - Deferred share activity (Details)
EquityInstruments in Thousands |
1 Months Ended |
12 Months Ended |
|
Nov. 30, 2017
USD ($)
|
Dec. 31, 2017
DKK (kr)
EquityInstruments
|
Dec. 31, 2017
USD ($)
EquityInstruments
|
Dec. 31, 2016
USD ($)
EquityInstruments
|
Dec. 31, 2015
USD ($)
EquityInstruments
|
Dec. 31, 2014
EquityInstruments
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
| Research and development costs | $ |
|
|
$ 4,852,000
|
$ 7,984,000
|
$ 6,000,000
|
|
| General and administrative costs | $ |
|
|
2,230,000
|
6,304,000
|
7,541,000
|
|
| Total | $ |
$ 11,700,000
|
|
$ 7,082,000
|
$ 14,288,000
|
$ 13,541,000
|
|
| Deferred shares |
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
| Outstanding at beginning |
|
3,517
|
3,517
|
4,814
|
5,686
|
|
| Granted |
|
900
|
900
|
125
|
550
|
|
| Vested and issued |
|
|
|
(1,422)
|
(1,422)
|
|
| Forfeited |
|
(2,842)
|
(2,842)
|
|
|
|
| Effect of the Amendment and the Deferred Share Adjustment |
|
(875)
|
(875)
|
|
|
|
| Outstanding at end |
|
700
|
700
|
3,517
|
4,814
|
5,686
|
| Vested and unissued |
|
234
|
234
|
|
|
|
| Exercise price |
|
kr 0.01
|
$ 0.0016
|
|
|
|
| Key Management Personnel | Deferred shares |
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
| Outstanding at beginning |
|
3,217
|
3,217
|
4,264
|
5,686
|
|
| Granted |
|
450
|
450
|
125
|
|
|
| Vested and issued |
|
|
|
(1,422)
|
(1,422)
|
|
| Transfer |
|
|
|
250
|
|
|
| Forfeited |
|
(2,842)
|
(2,842)
|
|
|
|
| Effect of the Amendment and the Deferred Share Adjustment |
|
(419)
|
(419)
|
|
|
|
| Outstanding at end |
|
406
|
406
|
3,217
|
4,264
|
5,686
|
| Vested and unissued |
|
127
|
127
|
|
|
|
| Employees and consultants | Deferred shares |
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
| Outstanding at beginning |
|
300
|
300
|
550
|
|
|
| Granted |
|
450
|
450
|
|
550
|
|
| Transfer |
|
|
|
(250)
|
|
|
| Effect of the Amendment and the Deferred Share Adjustment |
|
(456)
|
(456)
|
|
|
|
| Outstanding at end |
|
294
|
294
|
300
|
550
|
|
| Vested and unissued |
|
107
|
107
|
|
|
|
| Chief Financial Officer | Deferred shares |
|
|
|
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
|
|
|
|
|
| Vesting term |
|
|
|
|
|
4 years
|